DAMAI ENT (01060) saw its shares surge more than 4% during intraday trading. As of the time of writing, the stock was up 2.17%, trading at HK$0.94, with a turnover of HK$58.2238 million. On the news front, at the 2025 Annual Conference of the Exhibition Exchange Professional Committee of the Chinese Museums Association held recently in Hangzhou, the China Cultural Heritage Exchange Center, in collaboration with DAMAI ENT's subsidiary "Yi Zhan Hong Tu" and cultural museum service provider "Zhong Chuang Yun Qi," jointly launched the "Cultural Integration, Digital Intelligence Together — Launch Plan" and the 2026 Museum "Special Exhibition Cooperation Plan." This initiative aims to unite museums across all levels nationwide to create innovative cultural museum special exhibition projects. This marks DAMAI ENT's first invitation to participate in the conference, signaling its official entry into the museum sector. Moving forward, DAMAI ENT plans to deepen its collaboration with museums across three key areas: exhibition marketing, content production, and ticketing systems. China Securities (CSC) pointed out that DAMAI ENT's IP business is performing strongly, with its domestic performance business likely to benefit from policy changes and its overseas operations set to gain from the implementation of hosted projects. Additionally, the company is expected to have significant involvement in production and distribution during the 2026 Spring Festival period. Western Securities previously stated that the company is strategically positioned in two high-growth sectors: live performances and IP derivatives. Its ticketing business provides a stable foundation, while Alibaba's "Alifish" platform is expected to offer earnings flexibility, allowing the company to fully benefit from the ongoing recovery and structural upgrade in offline entertainment consumption.